| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 35.056 | 96.863 | 158.362 | 327.756 | 424.476 | 451.324 | 526.959 | 612.721 | 444.449 | 260.069 |
| Total Income - EUR | 35.064 | 96.868 | 158.363 | 327.758 | 424.479 | 451.359 | 527.175 | 612.831 | 455.595 | 260.071 |
| Total Expenses - EUR | 23.355 | 67.377 | 109.137 | 177.325 | 213.953 | 201.752 | 258.495 | 283.909 | 274.017 | 235.208 |
| Gross Profit/Loss - EUR | 11.709 | 29.491 | 49.226 | 150.434 | 210.526 | 249.607 | 268.680 | 328.922 | 181.578 | 24.863 |
| Net Profit/Loss - EUR | 10.678 | 28.522 | 45.023 | 147.156 | 206.281 | 245.851 | 263.819 | 323.790 | 177.426 | 16.324 |
| Employees | 4 | 6 | 7 | 7 | 7 | 7 | 7 | 9 | 7 | 6 |
Check the financial reports for the company - Endodiabet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 28.225 | 37.191 | 54.833 | 64.682 | 67.852 | 58.870 | 31.416 | 11.659 | 119.172 | 125.463 |
| Current Assets | 2.957 | 19.690 | 33.628 | 92.064 | 167.093 | 211.542 | 254.079 | 330.974 | 166.722 | 23.430 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.398 |
| Receivables | 2.800 | 8.069 | 8.316 | 43.945 | 97.894 | 110.689 | 134.905 | 244.053 | 159.469 | 16.874 |
| Cash | 158 | 0 | 25.312 | 48.119 | 69.199 | 100.853 | 119.174 | 46.365 | 7.254 | 4.158 |
| Shareholders Funds | 13.226 | 31.044 | 47.502 | 149.590 | 206.357 | 245.934 | 263.899 | 323.871 | 177.507 | 21.561 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 17.957 | 25.837 | 40.958 | 7.157 | 28.588 | 24.478 | 21.596 | 18.762 | 108.388 | 127.332 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endodiabet Srl